Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Demant (WILLF – Research Report) and ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Guardant Health Inc (GH) stock saw a decline, ending the day at $47.21 which represents a decrease of $-1.39 or -2.86% from the prior close of $48.6. The stock opened at $48.26 and touched a low of ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for Guardant Health in a research report issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now ...

In terms of valuation, Guardant Health Inc’s market capitalization stands at $6.00 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Fintel reports that on January 23, 2025, Barclays initiated coverage of Guardant Health (NasdaqGS:GH) with a Overweight ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating yesterday.Invest with Confidence: ...

On Tuesday, 10 companies—mostly under the space exploration, energy, and quantum computing sectors—registered the highest ...

Wealthcare Advisory Partners LLC acquired a new position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities ...

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...